NfL levels correlate to greater disease severity, lower scores at cognitive tests, and shorter survival, suggesting that they may help differentiate FTD patients who will progress over time from those who have a clinical diagnosis of FTD but do not progress over time, indicated as “phenocopies” [3]. The gene discussed is NEFL; the disease is frontotemporal dementia.